JODY ROACH: Open Payments
NPI 1467976993 · COSHOCTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 19 payments from 11 companies in 2025. Trend: 2023 $1,263 · 2024 $817 · 2025 $459
Food & beverage: $420Education: $40
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $89 |
| ABBVIE INC. | 4 | $68 |
| Madrigal Pharmaceuticals | 1 | $64 |
| Phathom Pharmaceuticals, Inc. | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Corcept Therapeutics | 1 | $29 |
| GENZYME CORPORATION | 1 | $27 |
| QOL Medical, LLC | 1 | $20 |
| Edwards Lifesciences Corporation | 1 | $18 |
Products named: XIFAXAN, REZDIFFRA, VOQUEZNA, DUPIXENT, ENTYVIO, CREON, LINZESS, Korlym.
Industry payments across OH — which companies pay providers there.
